Raynauds Disease Treatment Global Market Report 2025

Published Jul 07, 2025

Length 175 Pages

SKU # BRC20166190

Description

Raynauds Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on raynauds disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for raynauds disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The raynauds disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Treatment Type: Medication; Thermal Therapies; Surgical Procedures; Alteative Therapies

2) By Drug Class: Calcium Channel Blockers; Vasodilators; Antiplatelet Agents

3) By Route of Administration: Oral; Topical; Injectable; Intravenous

4) By End-User: Hospitals; Specialty Clinics; Homecare Settings; Pharmacies

Subsegments:

1) By Medication: Calcium Channel Blockers; Alpha Blockers; Vasodilators; Topical Nitrates; Selective Serotonin Reuptake Inhibitors (SSRIs); Phosphodiesterase Inhibitors; Angiotensin Receptor Blockers (ARBs)

2) By Thermal Therapies: Hand Warmers; Thermal Gloves; Heated Pads; Biofeedback-Controlled Thermal Devices

3) By Surgical Procedures: Sympathectomy; Nerve Decompression Surgery; Vascular Surgery

4) By Alternative Therapies: Acupuncture; Biofeedback Therapy; Herbal Remedies; Nutritional Supplements; Stress Management Techniques

Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Bayer AG; Novartis AG; Sanofi SA

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

1. Executive Summary
2. Raynauds Disease Treatment Market Characteristics
3. Raynauds Disease Treatment Market Trends And Strategies
4. Raynauds Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Raynauds Disease Treatment Growth Analysis And Strategic Analysis Framework: 5.1. Global Raynauds Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints); 5.2. Analysis Of End Use Industries; 5.3. Global Raynauds Disease Treatment Market Growth Rate Analysis; 5.4. Global Raynauds Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion); 5.5. Global Raynauds Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion); 5.6. Global Raynauds Disease Treatment Total Addressable Market (TAM)
6. Raynauds Disease Treatment Market Segmentation: 6.1. Global Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Medication; Thermal Therapies; Surgical Procedures; Alteative Therapies; 6.2. Global Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Calcium Channel Blockers; Vasodilators; Antiplatelet Agents; 6.3. Global Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Oral; Topical; Injectable; Intravenous; 6.4. Global Raynauds Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hospitals; Specialty Clinics; Homecare Settings; Pharmacies; 6.5. Global Raynauds Disease Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Calcium Channel Blockers; Alpha Blockers; Vasodilators; Topical Nitrates; Selective Serotonin Reuptake Inhibitors (SSRIs); Phosphodiesterase Inhibitors; Angiotensin Receptor Blockers (ARBs); 6.6. Global Raynauds Disease Treatment Market, Sub-Segmentation Of Thermal Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hand Warmers; Thermal Gloves; Heated Pads; Biofeedback-Controlled Thermal Devices; 6.7. Global Raynauds Disease Treatment Market, Sub-Segmentation Of Surgical Procedures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Sympathectomy; Nerve Decompression Surgery; Vascular Surgery; 6.8. Global Raynauds Disease Treatment Market, Sub-Segmentation Of Alteative Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Acupuncture; Biofeedback Therapy; Herbal Remedies; Nutritional Supplements; Stress Management Techniques
7. Raynauds Disease Treatment Market Regional And Country Analysis: 7.1. Global Raynauds Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 7.2. Global Raynauds Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Raynauds Disease Treatment Market: 8.1. Asia-Pacific Raynauds Disease Treatment Market Overview; Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies; 8.2. Asia-Pacific Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.3. Asia-Pacific Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.4. Asia-Pacific Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Raynauds Disease Treatment Market: 9.1. China Raynauds Disease Treatment Market Overview; 9.2. China Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.3. China Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.4. China Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Raynauds Disease Treatment Market: 10.1. India Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.2. India Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.3. India Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Raynauds Disease Treatment Market: 11.1. Japan Raynauds Disease Treatment Market Overview; 11.2. Japan Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.3. Japan Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.4. Japan Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Raynauds Disease Treatment Market: 12.1. Australia Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.2. Australia Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.3. Australia Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Raynauds Disease Treatment Market: 13.1. Indonesia Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.2. Indonesia Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.3. Indonesia Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Raynauds Disease Treatment Market: 14.1. South Korea Raynauds Disease Treatment Market Overview; 14.2. South Korea Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.3. South Korea Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.4. South Korea Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Raynauds Disease Treatment Market: 15.1. Western Europe Raynauds Disease Treatment Market Overview; 15.2. Western Europe Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.3. Western Europe Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.4. Western Europe Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Raynauds Disease Treatment Market: 16.1. UK Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.2. UK Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.3. UK Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Raynauds Disease Treatment Market: 17.1. Germany Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.2. Germany Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.3. Germany Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Raynauds Disease Treatment Market: 18.1. France Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.2. France Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.3. France Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Raynauds Disease Treatment Market: 19.1. Italy Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.2. Italy Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.3. Italy Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Raynauds Disease Treatment Market: 20.1. Spain Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.2. Spain Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.3. Spain Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Raynauds Disease Treatment Market: 21.1. Eastern Europe Raynauds Disease Treatment Market Overview; 21.2. Eastern Europe Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.3. Eastern Europe Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.4. Eastern Europe Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Raynauds Disease Treatment Market: 22.1. Russia Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.2. Russia Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.3. Russia Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Raynauds Disease Treatment Market: 23.1. North America Raynauds Disease Treatment Market Overview; 23.2. North America Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.3. North America Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.4. North America Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Raynauds Disease Treatment Market: 24.1. USA Raynauds Disease Treatment Market Overview; 24.2. USA Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.3. USA Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.4. USA Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Raynauds Disease Treatment Market: 25.1. Canada Raynauds Disease Treatment Market Overview; 25.2. Canada Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.3. Canada Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.4. Canada Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Raynauds Disease Treatment Market: 26.1. South America Raynauds Disease Treatment Market Overview; 26.2. South America Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.3. South America Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.4. South America Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Raynauds Disease Treatment Market: 27.1. Brazil Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.2. Brazil Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.3. Brazil Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Raynauds Disease Treatment Market: 28.1. Middle East Raynauds Disease Treatment Market Overview; 28.2. Middle East Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.3. Middle East Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.4. Middle East Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Raynauds Disease Treatment Market: 29.1. Africa Raynauds Disease Treatment Market Overview; 29.2. Africa Raynauds Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.3. Africa Raynauds Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.4. Africa Raynauds Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Raynauds Disease Treatment Market Competitive Landscape And Company Profiles: 30.1. Raynauds Disease Treatment Market Competitive Landscape; 30.2. Raynauds Disease Treatment Market Company Profiles; 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis; 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis; 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis; 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis; 30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
31. Raynauds Disease Treatment Market Other Major And Innovative Companies: 31.1. Bristol-Myers Squibb Company; 31.2. AstraZeneca PLC; 31.3. GlaxoSmithKline plc; 31.4. Takeda Pharmaceutical Company Limited; 31.5. Eli Lilly and Company; 31.6. Merck & Co. Inc.; 31.7. Teva Pharmaceutical Industries Ltd.; 31.8. CSL Vifor; 31.9. Orion Corporation; 31.10. Apricus Biosciences Inc.; 31.11. Vicore Pharma Holding AB; 31.12. MediQuest Therapeutics Inc.; 31.13. Gesynta Pharma AB; 31.14. Aisa Pharma Inc.; 31.15. Concert Pharmaceuticals Inc.
32. Global Raynauds Disease Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Raynauds Disease Treatment Market
34. Recent Developments In The Raynauds Disease Treatment Market
35. Raynauds Disease Treatment Market High Potential Countries, Segments and Strategies: 35.1 Raynauds Disease Treatment Market In 2029 - Countries Offering Most New Opportunities; 35.2 Raynauds Disease Treatment Market In 2029 - Segments Offering Most New Opportunities; 35.3 Raynauds Disease Treatment Market In 2029 - Growth Strategies; 35.3.1 Market Trend Based Strategies; 35.3.2 Competitor Strategies
36. Appendix: 36.1. Abbreviations; 36.2. Currencies; 36.3. Historic And Forecast Inflation Rates; 36.4. Research Inquiries; 36.5. The Business Research Company; 36.6. Copyright And Disclaimer

Pricing

Currency Rates

Single User Email from Publisher $4,490
Site License Fulfilled by Publisher $6,490
Global Site License Email from Publisher $8,490

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now